Mechanistically, studies of patients with ARVC suggest that a variety of PKP2 mutations (insertions or deletions, nonsense, missense) lead to haploinsufficiency and therefore a reduction in myocardial PKP2 protein levels11–13. Here, PKP2 is linked to arrhythmogenic right ventricular cardiomyopathy.